Search Results
2-(1,8-naphthyridin-2-yl)phenol 5 mg | 99.84%
TargetMol
Scopolamine butylbromide 100 mg | 99.02%
TargetMol

Scopolamine butylbromide is a competitive antagonist of mAChR (IC50: 55.3 ± 4.3 nM).
More Information Supplier PageOrthanilamide 100 mg | Purity Not Available
TargetMol
2-Aminobenzenesulfonamide is a molecule containing the sulfonamide functional group attached to an aniline.
More Information Supplier Page10-Deacetylbaccatin III 100 mg | 98.84%
TargetMol

10-Deacetylbaccatin-III is an intermediate for taxol analog preparations with anti-cancer activity.
More Information Supplier PageAcefylline 100 mg | 99.95%
TargetMol

Acefylline (Theophylline-7-acetic acid), a stimulant drug of the xanthine chemical class, acts as an adenosine receptor antagonist. It is combined with diphenhydramine in the pharmaceutical preparation Etanautine to help offset its stimulant effects
More Information Supplier PageICG001 100 mg | 98.63%
TargetMol

ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information Supplier PageICG001 25 mg | 98.63%
TargetMol

ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information Supplier PageICG001 5 mg | 98.63%
TargetMol

ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information Supplier PageIM-12 10 mg | 99.42%
TargetMol

IM-12, an effective GSK-3β inhibitor(IC50=53 nM), regulates Wnt signalling.
More Information Supplier Page